Rheologics

Rheologics was a medical technology company specializing in clinical hemorheology, the study of blood flow and viscosity. The company developed the RheoAnalyzer, a diagnostic device designed to measure whole blood viscosity across a range of shear rates, providing clinicians with data to assess cardiovascular risk and manage conditions like diabetes and peripheral arterial disease. By focusing on the physical properties of blood, Rheologics aimed to provide a more comprehensive understanding of vascular health beyond traditional biochemical markers. The company's technology was utilized in various clinical trials to evaluate the impact of blood rheology on stroke and heart disease. Although the company is no longer active, its innovations significantly advanced the field of blood flow analysis in clinical settings.